Volker Meske

3.4k total citations
26 papers, 799 citations indexed

About

Volker Meske is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Volker Meske has authored 26 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 8 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Volker Meske's work include Alzheimer's disease research and treatments (14 papers), Lysosomal Storage Disorders Research (10 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Volker Meske is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Lysosomal Storage Disorders Research (10 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Volker Meske collaborates with scholars based in Germany, United States and Sweden. Volker Meske's co-authors include Thomas G. Ohm, Frank Albert, S. Treiber-Held, Frauke Glöckner, E. Hartmann, Juan-Enrique Schwarze, Daniel Richter, K. Harzer, Wolfgang Müller and Winfried März and has published in prestigious journals such as Journal of Biological Chemistry, Neuroscience and Journal of Neurochemistry.

In The Last Decade

Volker Meske

26 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volker Meske Germany 16 520 337 177 127 84 26 799
Elma Aflaki United States 17 600 1.2× 425 1.3× 129 0.7× 132 1.0× 213 2.5× 26 1.3k
Lauren S. Whyte Australia 10 220 0.4× 217 0.6× 156 0.9× 147 1.2× 83 1.0× 13 664
Lucie Delattre France 7 423 0.8× 365 1.1× 44 0.2× 160 1.3× 25 0.3× 7 704
Afshin Safavi United States 6 573 1.1× 362 1.1× 60 0.3× 165 1.3× 23 0.3× 9 837
Santosh Ramamurthy United States 11 191 0.4× 384 1.1× 127 0.7× 120 0.9× 119 1.4× 12 696
Karin Müllendorff United States 8 429 0.8× 473 1.4× 68 0.4× 244 1.9× 63 0.8× 8 820
Jeho Shin United States 10 531 1.0× 386 1.1× 56 0.3× 60 0.5× 105 1.3× 11 903
Petronela Weisová Ireland 13 165 0.3× 490 1.5× 80 0.5× 182 1.4× 123 1.5× 17 755
Jean‐Michel Itier France 6 383 0.7× 276 0.8× 157 0.9× 149 1.2× 26 0.3× 6 656
Daniel Cacabelos Spain 14 196 0.4× 387 1.1× 52 0.3× 88 0.7× 82 1.0× 19 875

Countries citing papers authored by Volker Meske

Since Specialization
Citations

This map shows the geographic impact of Volker Meske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Meske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Meske more than expected).

Fields of papers citing papers by Volker Meske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Meske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Meske. The network helps show where Volker Meske may publish in the future.

Co-authorship network of co-authors of Volker Meske

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Meske. A scholar is included among the top collaborators of Volker Meske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Meske. Volker Meske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meske, Volker, et al.. (2019). NPC1-deficient neurons are selectively vulnerable for statin treatment. Neuropharmacology. 151. 159–170. 4 indexed citations
2.
Meske, Volker, et al.. (2014). How to reduce the accumulation of autophagic vacuoles in NPC1-deficient neurons: A comparison of two pharmacological strategies. Neuropharmacology. 89. 282–289. 8 indexed citations
3.
Meske, Volker, et al.. (2014). The autophagic defect in Niemann–Pick disease type C neurons differs from somatic cells and reduces neuronal viability. Neurobiology of Disease. 64. 88–97. 37 indexed citations
4.
Glöckner, Frauke, Volker Meske, Dieter Lütjohann, & Thomas G. Ohm. (2011). Dietary Cholesterol and Its Effect on Tau Protein: A Study in Apolipoprotein E-Deficient and P301L Human Tau Mice. Journal of Neuropathology & Experimental Neurology. 70(4). 292–301. 31 indexed citations
5.
Meske, Volker, Frank Albert, & Thomas G. Ohm. (2007). Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3β-dependent Phosphorylation of Tau. Journal of Biological Chemistry. 283(1). 100–109. 79 indexed citations
6.
Ohm, Thomas G. & Volker Meske. (2006). Cholesterol, statins and tau. Acta Neurologica Scandinavica. 114(s185). 93–101. 15 indexed citations
7.
Meske, Volker, Frank Albert, & Thomas G. Ohm. (2004). Cell Cultures of Autopsy-Derived Fibroblasts. Humana Press eBooks. 107. 111–124. 4 indexed citations
8.
Deisz, Rudolf A., Volker Meske, S. Treiber-Held, Frank Albert, & Thomas G. Ohm. (2004). Pathological cholesterol metabolism fails to modify electrophysiological properties of afflicted neurones in Niemann-Pick disease type C. Neuroscience. 130(4). 867–873. 15 indexed citations
9.
Treiber-Held, S., et al.. (2003). Cholesterol storage and tau pathology in Niemann–Pick type C disease in the brain. The Journal of Pathology. 200(1). 104–111. 74 indexed citations
10.
Meske, Volker, Frank Albert, Daniel Richter, Juan-Enrique Schwarze, & Thomas G. Ohm. (2003). Blockade of HMG‐CoA reductase activity causes changes in microtubule‐stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease. European Journal of Neuroscience. 17(1). 93–102. 89 indexed citations
11.
Ohm, Thomas G., et al.. (2003). Plasticity and the Spread of Alzheimer's Disease-Like Changes. Neurochemical Research. 28(11). 1715–1723. 8 indexed citations
12.
Ohm, Thomas G., et al.. (2003). Cholesterol and Tau Protein - Findings in Alzheimer’s and Niemann Pick C’s Disease. Pharmacopsychiatry. 36. 120–126. 51 indexed citations
13.
14.
Glöckner, Frauke, Volker Meske, & Thomas G. Ohm. (2002). Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer’s disease. Neuroscience. 114(4). 1103–1114. 31 indexed citations
15.
Meske, Volker, et al.. (2001). Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathologica. 101(6). 547–554. 70 indexed citations
16.
Meske, Volker, et al.. (2000). Microdensitofluorometrically determined free cholesterol is higher in tangle-bearing neurons than in tangle-free neurons. Neurobiology of Aging. 21. 21–21. 5 indexed citations
17.
18.
Müller, Wolfgang, et al.. (1998). Apolipoprotein E Isoforms Increase Intracellular Ca2+ Differentially Through a ω‐Agatoxin IVa‐Sensitive Ca2+‐Channel. Brain Pathology. 8(4). 641–653. 60 indexed citations
19.
20.
Meske, Volker & E. Hartmann. (1995). Reorganization of microfilaments in protonemal tip cells of the mossCeratodon purpureus during the phototropic response. PROTOPLASMA. 188(1-2). 59–69. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elma Aflaki Breakdown of academic impact, for papers by Lauren S. Whyte Breakdown of academic impact, for papers by Lucie Delattre Breakdown of academic impact, for papers by Afshin Safavi Breakdown of academic impact, for papers by Santosh Ramamurthy Breakdown of academic impact, for papers by Karin Müllendorff Breakdown of academic impact, for papers by Jeho Shin Breakdown of academic impact, for papers by Petronela Weisová Breakdown of academic impact, for papers by Jean‐Michel Itier Breakdown of academic impact, for papers by Daniel Cacabelos
Rankless by CCL
2026